Study Stopped
PI did decided reorganize the methodology for this study and will resubmit in the future.
The Effects of Adding Expiratory Muscle Strength Training in Voice Therapy
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Evaluate if adding expiratory muscle strength training to traditional voice therapy for individuals with dysphonia due to glottal insufficiency improves maximal expiratory pressure, acoustic and aerodynamic measures (i.e. amplitude, maximum phonation time, peak expiratory flow), and voice related quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2018
CompletedFirst Posted
Study publicly available on registry
October 2, 2018
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
February 7, 2025
February 1, 2025
1.7 years
September 26, 2018
February 4, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Maximum expiratory pressure
Maximum expiratory pressure, in cm of H2O, will be measured to evaluate how much pressure a participant can blow into a respiratory pressure meter.
16 weeks
Amplitude
Amplitude of voice, in decibels, will be measured using Voice Range Profile on Kay Pentax CSL and will be compared to gender matched normative values for normal and loud volumes.
16 weeks
Secondary Outcomes (7)
Fundamental frequency
16 weeks
Dynamic pitch range
16 weeks
Cepstral Peak Prominence (CPP)
16 weeks
Cepstral spectral index of dysphonia (CSID)
16 weeks
Voice Handicap Index
16 weeks
- +2 more secondary outcomes
Study Arms (3)
Unilateral vocal fold paralysis standard of care voice therapy
EXPERIMENTALThe participants will receive the standard of voice therapy including improved breath coordination, sustained humming and vowels, vocal glides, resonant voice therapy, and relations techniques.
Unilateral paralysis standard of care voice therapy plus EMST
EXPERIMENTALThe participants will receive the standard of voice therapy including improved breath coordination, sustained humming and vowels, vocal glides, resonant voice therapy, and relations techniques. EMST consists of blowing into respiratory device at a measure threshold pressure. As strength improves threshold resistance will be increased.
Parkinson's disease standard of care voice therapy plus EMST
EXPERIMENTALThe participants will receive the standard of voice therapy including improved breath coordination, sustained humming and vowels, vocal glides, resonant voice therapy, and relations techniques. EMST consists of blowing into respiratory device at a measure threshold pressure. As strength improves threshold resistance will be increased.
Interventions
Exercises will include improved breath coordination, sustained humming and vowels, vocal glides, resonant voice therapy, and relaxation techniques to the neck and shoulder
EMST150 used at 75% of their maximum expiratory pressure. Participants will be directed to perform 5 sets of 5 breaths, 5 days per week, for 5 weeks, at the pressure threshold established in therapy. Maximum expiratory pressure will then be determined at the beginning of each therapy session and recalibration of the device will be performed if indicated.
Eligibility Criteria
You may qualify if:
- Individuals with glottic insufficiency.
- Adequate cognition evidenced by score of 24 or higher on the Mini-Mental State Examination (MMSE) survey to determine if the subject has the mental capacity to participate in therapy
- Completed voice combination evaluation with speech pathologists and otolaryngologist.
- Individuals 18 years of age or older
You may not qualify if:
- Adults unable to consent
- Non English or Spanish speakers
- Pregnant women
- Prisoners
- Individuals with significant uncontrolled chronic and progressive respiratory diseases including COPD, interstitial lung disease, and cystic fibrosis.
- Individuals with uncontrolled blood pressure.
- Individuals with significant GI disease and/or gastroesophageal surgery with the exception of well-controlled GERD.
- Individuals with a history of abdominal hernia.
- Individuals with difficulty complying due to neuropsychological dysfunction (e.g., severe depression, psychosis).
- Individuals with other neurological disorders and/or neuromuscular disease other than Parkinson's Disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami
Miami, Florida, 33136, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adam T Lloyd, SLP-D, MM, MA
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Speech Pathologist
Study Record Dates
First Submitted
September 26, 2018
First Posted
October 2, 2018
Study Start
April 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
February 7, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share